- Home
- OGI vs CYBN Comparison
OGI vs CYBN Comparison
Compare OGI & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- CYBN
- Stock Information
- Founded
- OGI 2013
- CYBN 2019
- Country
- OGI Canada
- CYBN Canada
- Employees
- OGI N/A
- CYBN N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- CYBN Pharmaceuticals and Biotechnology
- Sector
- OGI Health Care
- CYBN Health Care
- Exchange
- OGI Nasdaq
- CYBN Nasdaq
- Market Cap
- OGI 135.1M
- CYBN 127.3M
- IPO Year
- OGI N/A
- CYBN N/A
- Fundamental
- Price
- OGI $1.07
- CYBN $7.35
- Analyst Decision
- OGI
- CYBN Strong Buy
- Analyst Count
- OGI 0
- CYBN 4
- Target Price
- OGI N/A
- CYBN $86.00
- AVG Volume (30 Days)
- OGI 484.7K
- CYBN 297.6K
- Earning Date
- OGI 05-13-2025
- CYBN 02-11-2025
- Dividend Yield
- OGI N/A
- CYBN N/A
- EPS Growth
- OGI N/A
- CYBN N/A
- EPS
- OGI N/A
- CYBN N/A
- Revenue
- OGI $115,451,336.00
- CYBN N/A
- Revenue This Year
- OGI $50.11
- CYBN N/A
- Revenue Next Year
- OGI $16.16
- CYBN N/A
- P/E Ratio
- OGI N/A
- CYBN N/A
- Revenue Growth
- OGI N/A
- CYBN N/A
- 52 Week Low
- OGI $0.85
- CYBN $4.81
- 52 Week High
- OGI $2.17
- CYBN $14.44
- Technical
- Relative Strength Index (RSI)
- OGI 52.89
- CYBN 55.25
- Support Level
- OGI $1.02
- CYBN $4.84
- Resistance Level
- OGI $1.11
- CYBN $8.09
- Average True Range (ATR)
- OGI 0.07
- CYBN 0.64
- MACD
- OGI 0.02
- CYBN 0.27
- Stochastic Oscillator
- OGI 84.62
- CYBN 77.44
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.